Luyao Gong
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Metabolic crosstalk in the metastatic prostate cancer-bone microenvironment: mechanism, detection and therapeutic strategies.
Journal: European journal of pharmacology
Published: August 23, 2025
IL-23 inhibitor enhances the effects of PTEN DNA-loaded lipid nanoparticles for metastatic CRPC therapy.
Journal: Frontiers in pharmacology
Published: February 20, 2024
MiR26a reverses enzalutamide resistance in a bone-tumor targeted system with an enhanced effect on bone metastatic CRPC.
Journal: Journal of nanobiotechnology
Published: January 09, 2024
Post-marketing surveillance framework of cell and gene therapy products in the European Union, the United States, Japan, South Korea and China: a comparative study.
Journal: BMC medicine
Published: October 24, 2023
The global patent landscape of mRNA for diagnosis and therapy.
Journal: Nature biotechnology
Published: September 12, 2023
Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics.
Journal: British journal of pharmacology
Published: June 13, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026